Bioequivalence and Bioavailability Forum

Dear all,

on Dec 18^th EMA and USFDA announced the launch of a joint initiative to share information on inspections of bioequivalence studies submitted in support of generic drug approvals.
The 18 months pilot phase will start on January 2^nd, 2014. For an overview see here.

The initiative is a follow-up on the collaboration on GCP-inspections started in 2009 (see here).